1. Nanotechnology

Category Archives: Nanotechnology

Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74 …

Posted on by

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/grcb6t/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering.

IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc Dominate the Market

Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.

The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp. plc, Debiotech SA, F. Hoffmann-La Roche Ltd., Nano Interface Technology Inc., Spherics Inc., Spectrum Pharmaceuticals Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals Inc., PharmaNova Inc., Particle Sciences Inc., Novavax Inc., Nanotherapeutics Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics Inc., Nano Interface Technology Inc., Merck Sharp & Dohme Corp., Kuecept Ltd., and Izon Science Ltd.

Key questions answered in this report:

- What will the market size be in 2016 and what will the growth rate be?

- What are the key market trends?

- What is driving this market?

- What are the challenges to market growth?

Go here to read the rest:

Research and Markets: Global Nanotechnology Drug Delivery Market Report 2013-2016: Market to Grow at a CAGR of 74 ...

Nanotechnology helps track and improve drug action in pancreatic cancer

Posted on by

Public release date: 12-Jun-2013 [ | E-mail | Share ]

Contact: Alison Heather a.heather@garvan.org.au 61-292-958-128 Garvan Institute of Medical Research

UK and Australian scientists have been able to show ways in which we can markedly improve drug targeting of solid tumours, using tiny 'biosensors' along with new advanced imaging techniques.

In real time and in three dimensions, these technologies can show us how cancers spread and how active cancer cells respond to a particular drug. They can also tell us how much, how often and how long to administer drugs. Finally, using preclinical models of the disease, they can guide the use of 'combination therapies', techniques that enhance drug delivery by breaking up the tissue surrounding a tumour.

The study was performed by Dr Paul Timpson of the Garvan Institute of Medical Research and Professor Kurt Anderson of the Beatson Institute for Cancer Research in Glasgow, UK. PhD student Max Nobis studied the signaling protein 'Src', which becomes activated to drive invasive pancreatic cancer, and looked at how it could best be deactivated by a small molecule inhibitor currently in phase II clinical trials known as 'dasatinib'. Their findings are published in the journal Cancer Research, now online.

"We have already shown that Src is activated in pancreatic tumours and we knew that dasatinib deactivates Src and could partially reduce the spread of this form of cancer. Through a collaborative partner in the US, we had access to FRET (Fluorescence Resonance Energy Transfer) imaging technology," said Dr Paul Timpson.

"Until now, we have been limited to studying tumour signalling in two dimensions and lacked a dynamic way of reporting on drug targeting in live tumour tissue. Nanotechnology opens up a portal into living tissue that allows us to watch cancers spreading, and to determine which parts of a tumour we should be targeting with drugs."

"This imaging technology has allowed us to map areas within the tumour that are highly aggressive, allowing us to pinpoint regions of poor drug delivery deep within a tumour at sub-cellular resolution. We can then see where we need to improve on drug delivery to improve clinical outcome."

It has been hard to treat pancreatic tumours because they are extremely dense with collagen and have poor blood vessel networks for delivering drugs.

Professor Kurt Anderson observed that combination therapies can now be used to break down collagen, weakening tumour architecture and making it easier to get the drugs where they need to be. "The trick is to break down the structure just enough to get the drug in, but not so much that you damage the organ itself," he said.

Read the original here:

Nanotechnology helps track and improve drug action in pancreatic cancer

Nanotechnology could lead to better batteries for EV's

Posted on by

If you search the Internet for information on nanotechnology the likelihood is that you will see a number of scare stories suggesting that nanotechnology robots will take over the world but if you dig a little deeper you will see that nanotechnology will play a major part in every area of our life going forward. Indeed researchers at the Los Alamos National Laboratory in New Mexico seem to have stumbled upon a new type of technology which could lead to batteries able to hold 10 times the storage capacity at the moment.

While the fact that these batteries could be commercially viable in the future is amazing in itself, it is also worth mentioning that unlike traditional batteries they do not require expensive precious metals such as platinum. This nanotechnology carbon-based catalyst is said to be able to squeeze maximum efficiency out of new lithium air technology which is currently being investigated by IBM for one.

The cost of electric vehicle batteries has been one of the main issues going forward for an industry which cannot seem to pull away from traditional battery restrictions. Historically there have been issues with the battery catalyst with the likes of platinum very expensive thereby reducing the overall cost efficiency of many electric vehicles.

Quote from ElectricForum.com : "I think with the large scale green movement that's helped a lot and things should be progressing fairly quickly with the updates in Graphine/Nano Technology."

There are still a number of issues to address with regards to this new technology, many of which seem to revolve around toxic and hazardous substances historically used to maximise battery efficiency. However, scientists on this particular research programme have come up with a solution which seems to work and involves the use of nitrogen and iron acetate to effectively skip the stage which creates the problem toxic and hazardous substances. It will be interesting to see how this particular issue develops because even if what we see today is not the finished product, it has given many scientists food for thought.

Electromobile image via Shutterstock.

Read more at ENN Affiliate, ElectricForum.

Read more:

Nanotechnology could lead to better batteries for EV's

Discovery 13: Internet of Things: Sensor-based Nanotechnology Research Futures Panel – Video

Posted on by


Discovery 13: Internet of Things: Sensor-based Nanotechnology Research Futures Panel
M2M sensor platforms are evolving from the convergence of nanotechnology with digital media, AI, manufacturing and communications. This presentation provokes...

By: OceDiscovery

Read this article:

Discovery 13: Internet of Things: Sensor-based Nanotechnology Research Futures Panel - Video

Rushford event celebrates nanotechnology

Posted on by

Posted: Wednesday, June 5, 2013 11:37 am

Rushford event celebrates nanotechnology Marion Renault Post-Bulletin Company, LLC

RUSHFORD It's the reason baseballs come off bats with a resounding crack, why dress shirts can be wrinkle-free and how doctors can treat breast cancer without invasive procedures: nanotechnology.

Alice Zimmer, a board member of Rushford Institute for NanoTechnology, likened the technology to taking a meter-long stick and cutting it into a billion pieces that is, examining things like manufacturing and medicine at the smallest possible level.

An online service is needed to view this article in its entirety. You need an online service to view this article in its entirety.

Need an account? Create one now.

kAm}2?@E649?@=@8J[ H9:49 92D =2C86=J 366? 56G6=@A65 😕 >6EC@A@=:E2? 2C62D 2?5 C6D62C49 F?:G6CD:E:6D[ 😀 ?@H 7@F?5 😕 CFC2= p>6C:42[ ?2>6=J D@FE962DE6C? |:??6D@E2]k^Am

kAm#FD97@C5!6E6CD@? w:89 $49@@= H:== 9@DE E96 7@FCE9 2??F2= }2?@E649?@=@8J s2J @? $2EFC52J[ 2 ;@:?E AC@;64E 36EH66? #x}%6< 2?5 $@FE962DE %649?:42= r@==686[ H9:49 C646:G65 2 Sgb_[___ 8C2?E 7C@> E96 }2E:@?2= $4:6?46 u@F?52E:@? 7@C DF49 <:?5D @7 4@>>F?:EJ @FEC6249]k^Am

kAm%96 >@C?:?8 H:== <:4< @77 H:E9 2 J@FE9 42>A[ H96C6 <:5D `c 2?5 @=56C 42? E2<6 A2CE :? 5:776C6?E 92?5D@? 6IA6C:>6?ED C6=2E65 E@ ?2?@E649?@=@8J] %96 @AA@CEF?:EJ 7@C <:5D E@ =62C? 23@FE 6>6C8:?8 D4:6?46D 62C=J @?[ D2:5 y@J46 xG6CD@?[ 2 #x}z%6< 3@2C5 >6>36C[ 😀 F?:BF6=J G2=F23=6 😕 4C62E:?8 E96 ?6IE 86?6C2E:@? @7 D4:6?E:DED]k^Am

kAmp Q}2?@E6< %C6

Follow this link:

Rushford event celebrates nanotechnology

Innovative new nanotechnology stops bed bugs in their tracks—literally

Posted on by

Javascript is currently disabled in your web browser. For full site functionality, it is necessary to enable Javascript. In order to enable it, please see these instructions. 5 hours ago A screen capture of a video demonstration of the new technology stopping bed bugs in their tracks.

Bed bugs now need to watch their step. Researchers at Stony Brook University have developed a safe, non-chemical resource that literally stops bed bugs in their tracks. This innovative new technology acts as a man-made web consisting of microfibers 50 times thinner than a human hair which entangle and trap bed bugs and other insects. This patent-pending technology is being commercialized by Fibertrap, a private company that employs non-toxic pest control methods.

The nanotech solution was developed at Stony Brook University's Center for Advanced Technology in Sensor Materials (Sensor CAT), a program funded by NYSTAR, as part of a statewide effort to encourage greater technological and economic collaboration between industry and research universities.

"Our nanotechnology produces entanglements that are millions of times more dense than woven products such as fabrics or carpets," said lead researcher Miriam Rafailovich, Distinguished Professor of Materials Science and Engineering and Co-Director in the Program of Chemical and Molecular Engineering at Stony Brook University. "The microfibers trap them by attaching to microstructures on their legs taking away their ability to move, which stops them from feeding and reproducing."

Successful tests were performed using live bed bugs and termites in Professor Rafailovich's lab with the assistance of Ying Liu, a scientist with Stony Brook University's Advanced Energy Research and Technology Center and Stony Brook graduate students Shan He and Linxi Zhang.

Kevin McAllister, Fibertrap's co-founder added, "We are very excited to move this advancement from the lab to the consumer. Our goal has always been to make a difference for people living in areas where bed bugs are pervasive and difficult to eradicate."

The microfibers are safe for humans and pets and unlike chemical treatments the insects cannot develop a resistance to it.

About bed bugs

Bed bugs (Cimex lectularius) are small, flat, parasitic insects that feed solely on the blood of people and animals while they sleep. Bed bugs are reddish-brown in color, wingless, range from one millimeter (mm) to seven mm (roughly the size of Lincoln's head on a penny), and can live several months without a blood meal.

Infestation

Read more from the original source:

Innovative new nanotechnology stops bed bugs in their tracks—literally


  1. Nanotechnology